Dosidal · Switzerland

Remifentanil Leman IV, poudre pour solution à diluer pour perfusion

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69918 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69918
atc: N01AH06
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2025-06-19
term: zugelassen
valid_until: 2030-06-18
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: N01AH06
authorisation_number: 69918
form: PULPI
holder: Leman SKL SA
holder_partner_nr: 1102953
it_number: 01.01.3.
name: Remifentanil Leman IV, poudre pour solution à diluer pour perfusion
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
moHIr0i91MAhkrmELDIlGx9EYiY7KiDwhJaGpPcnGY1DGfcH8Wt4XUmiJG0hicVhJkQhwkp68X8nKE06zD3GyQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:69918 · Same medicine in other markets · Dosidal